slides · global inventory
Paragraph
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 118,578
Current window 98,941-98,970
Pages 3,953
Rows per page 30
Component
98,941-98,970 of 118,578
21
Combines market sizing data with a 'Why Now' narrative supported by industry news clippings and a comparative efficacy table.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · InterestLoop · Golden Circle1 hit
22
The slide uses a wave-like visual to represent market segments and their associated valuations.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · InterestLoop · Golden Circle1 hit
32
The diagram illustrates a classic dose-escalation study design.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Desire1 hit
37
Includes a process flow diagram illustrating the mechanism of action of iMX-110 in turning cold tumors hot.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Desire1 hit
46
The slide uses a process-like structure to map the platform pillars to specific product outputs.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
47
Includes technical diagrams of the drug molecule, comparative histology, and survival curves.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Action1 hit
08
Uses a before-after framework to illustrate strategic evolution.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Early StrugglesLoop · Before After1 hit
13
Waterfall chart shows H1 22 to H1 23 bridge with Comparable, Scope, and FX impacts. Donut chart includes a central map graphic.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Rising Success1 hit
15
The slide uses a donut chart to show the 77%/23% split between Retail and Wholesale, with further regional and sub-channel breakdowns.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Rising Success1 hit
27
Waterfall chart illustrates revenue bridge from H1 2022 to H1 2023.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
35
The slide uses a donut chart as a central hub to connect the three categories of directors.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
38
EP&L stands for Environmental Profit & Loss. The slide uses a bubble matrix to show impact distribution and a line chart to show intensity reduction over time.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
39
The slide highlights geographic concentration in Italy and the formalization of sustainability through specific standards and audit cycles.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
48
Includes H1 2023 revenue of €833m, store count of 279, and regional revenue splits alongside quarterly YoY comparable growth rates.Kering | Investor Presentation Deck | 55 slides · Kering
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
03
Note at bottom: Lakeland's fiscal year end is January 31Lakeland Bancorp | Results Presentation Deck | 14 slides · Lakeland
Conference presentation Investor relations Beat · Setup1 hit
04
The slide uses a color-coded grid to map product categories to specific industry applications.Lakeland Bancorp | Results Presentation Deck | 14 slides · Lakeland
Conference presentation Investor relations Loop · Voice Of Customer1 hit
01
MindMed | Investor Presentation Deck | 32 slidesMindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
02
MindMed | Investor Presentation Deck | 32 slidesMindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
04
Uses a visual icon array to represent the '1 in 4' statistic.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
The slide uses a Gantt-style chart to show the progress of various drug candidates.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
06
The slide uses a circular flywheel diagram to represent the IP strategy and a horizontal bar chart to illustrate market exclusivity duration.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
07
The slide uses a simple list format to highlight two key upcoming clinical milestones.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
08
Uses a brain diagram to map specific therapeutic areas to clinical evidence points.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
Uses scientific visualization to illustrate the drug's impact on brain function.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
11
Uses a nested circle diagram to visualize the funnel of patients from total prevalence to treatment non-responders.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
12
The slide uses a table to establish clinical credibility for the MM-120 program by citing historical and contemporary research.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
18
The slide outlines the strategic rationale for a specific clinical trial phase.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
24
The chart shows improvement in social anxiety at 1 month and 6 months, indicating durability of effect.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
26
The slide highlights three pillars of collaboration: discovery engine, drug delivery, and clinical testing.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit
27
The slide highlights a strategic partnership and the resulting research pipeline.MindMed | Investor Presentation Deck | 32 slides · MindMed
Pitch deck Investor relations 1 hit